Startup | May 20, 2024
IIHMR Start-ups inks MoU with BMCHRC & HCG Hospital
The collaboration aims to bolster healthcare entrepreneurship
The collaboration aims to bolster healthcare entrepreneurship
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The award recognizes powerful science–industry collaborations for social good
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million
At the recommended Phase 3 dose of 200 mg vepdegestrant in combination with palbociclib, patients achieved a median progression-free survival of 13.9 months
Annapurna will lead the company in India ensuring patient access to its highly innovative medicines and vaccines
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
225Ac-PSMA-Trillium is an investigational next-generation PSMA-targeted alpha therapy with potential to treat patients with advanced metastatic prostate cancer
Subscribe To Our Newsletter & Stay Updated
